Insulin Glargine
compare suppliers & send inquiries for free
Filters
Reset
Selected filters:
Type
Region
Qualifications
Country of origin
Producer
Produced in:
Established in: 2019
MOQ: 1 g
Employees: 10+

Focused on pharmaceutical industry

Reasonable price for the customers

Full service from R&D stage to commercial stage
+ 0
All certificates
Send inquiry
Replies quickly
Send inquiry
Replies slower than most
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Producer

Fermentation technology Experts

Partnerships with 1200 pharma companies in 100+ countries

US FDA, EMA, COFEPRIES, ANVISA, PMDA accreditations
+ 0
All certificates
Send inquiry
Replies quickly
Looking for Insulin Glargine 160337-95-1?
- Description:
- Here you will find a list of producers, manufacturers and traders of Insulin Glargine. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Insulin Glargine
- Synonyms:
- Insulin Glargine (rDNA origin) , Insulin glargine recombinant
- Cas Number:
- 160337-95-1
- DrugBank number:
- DB00047
- Unique Ingredient Identifier:
- 2ZM8CX04RZ
About Insulin Glargine
Want to know what Insulin glargine is used for? Insulin glargine is a long-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is typically prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the pancreas that promotes glucose metabolism. Insulin is released from the pancreas following a meal to promote the uptake of glucose from the blood into internal organs and tissues such as the liver, fat cells, and skeletal muscle. Absorption of glucose into cells allows for its transformation into glycogen or fat for storage.
Insulin also inhibits hepatic glucose production, enhances protein synthesis, and inhibits lipolysis and proteolysis. Insulin is an important treatment in the management of Type 1 Diabetes (T1D), which is caused by an autoimmune reaction that destroys the beta cells of the pancreas, resulting in the body not being able to produce or synthesize the insulin needed to manage circulating blood sugar levels. As a result, people with T1D rely primarily on exogenous forms of insulin, such as insulin glargine, to lower glucose levels in the blood.
You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.
Insulin Glargine manufacturers | traders | suppliers
We have 3 companies offering Insulin Glargine from 2 different countries.
Get in contact with the supplier of your choice:
- Apino Pharma Co., Ltd. from China
- Wockhardt from India
- Biocon from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.